Congenital disorders of neuromuscular transmission.
Pathology underlying congenital forms of myasthenia gravis has been delineated through microscopic and electrophysiologic studies over the past 15 years. Differentiation from the immune-mediated disorder is crucial because therapy appropriate for acquired myasthenia may be harmful to patients with congenital disease.